FI901170A0 - Intercellulaer adhesionmolekyl-2 och dess bindeligander. - Google Patents

Intercellulaer adhesionmolekyl-2 och dess bindeligander.

Info

Publication number
FI901170A0
FI901170A0 FI901170A FI901170A FI901170A0 FI 901170 A0 FI901170 A0 FI 901170A0 FI 901170 A FI901170 A FI 901170A FI 901170 A FI901170 A FI 901170A FI 901170 A0 FI901170 A0 FI 901170A0
Authority
FI
Finland
Prior art keywords
molecules
intercellulaer
bindeligander
adhesionmolekyl
och dess
Prior art date
Application number
FI901170A
Other languages
English (en)
Other versions
FI100994B (fi
Inventor
Timothy Alan Springer
Michael Loran Dustin
Donald E Staunton
Original Assignee
Blood Res Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blood Res Center filed Critical Blood Res Center
Publication of FI901170A0 publication Critical patent/FI901170A0/fi
Application granted granted Critical
Publication of FI100994B publication Critical patent/FI100994B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
FI901170A 1989-03-09 1990-03-08 Menetelmä valmistaa ICAM-2 ja yhdistelmä-DNA-molekyyli FI100994B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32123889A 1989-03-09 1989-03-09
US32123889 1989-03-09
US45429489A 1989-12-22 1989-12-22
US45429489 1989-12-22

Publications (2)

Publication Number Publication Date
FI901170A0 true FI901170A0 (fi) 1990-03-08
FI100994B FI100994B (fi) 1998-03-31

Family

ID=26982877

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901170A FI100994B (fi) 1989-03-09 1990-03-08 Menetelmä valmistaa ICAM-2 ja yhdistelmä-DNA-molekyyli

Country Status (16)

Country Link
EP (1) EP0387668B1 (fi)
JP (1) JP3369166B2 (fi)
KR (1) KR0169728B1 (fi)
AT (1) ATE146222T1 (fi)
AU (1) AU647017B2 (fi)
CA (1) CA2011633C (fi)
DE (1) DE69029336T2 (fi)
DK (1) DK0387668T3 (fi)
ES (1) ES2097747T3 (fi)
FI (1) FI100994B (fi)
GR (1) GR3022670T3 (fi)
HU (1) HU214247B (fi)
IL (1) IL93680A (fi)
MX (1) MX9203469A (fi)
NO (1) NO178862C (fi)
NZ (2) NZ245651A (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
ATE184049T1 (de) * 1990-07-20 1999-09-15 Bayer Ag Multimere formen des menschlichen rhinovirus- rezeptorproteins
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
RO115415B1 (ro) * 1991-06-11 2000-02-28 Center For Blood Research, Inc. Moleculă-3 de adeziune intercelulară (icam-3), moleculă adn recombinant care o codifică, anticorpi ai acesteia, metodă de producere a celulei hibridoma, metode de modulare a funcţiilor biologice, de suprimare, identificare, diagnoză şi compoziţii farmaceutice
US5861151A (en) * 1991-12-20 1999-01-19 Bristol-Myers Squibb Co Soluble fusion molecules with binding specificity for cell adhesion molecules
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
WO1993014776A1 (en) * 1992-01-27 1993-08-05 Icos Corporation Icam-related protein
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US5773218A (en) * 1992-01-27 1998-06-30 Icos Corporation Method to identify compounds which modulate ICAM-related protein interactions
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
AU3657893A (en) * 1992-02-28 1993-09-13 Board Of Regents, The University Of Texas System Compositions and methods for the treatment of thermal injury
ATE161192T1 (de) * 1992-08-21 1998-01-15 Genentech Inc Verfahren zur behandlung einer durch lfa-1 vermittelten störung
WO1994011400A1 (en) * 1992-11-18 1994-05-26 Helsinki University Licensing Ltd. Oy Peptides from human icam-2 and from human icam-1 and their analogs for use in therapy and diagnosis
WO1997011168A1 (en) * 1995-09-22 1997-03-27 Relag Pty. Limited Promoter and uses thereof
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
WO2000056363A1 (en) 1999-03-19 2000-09-28 Genentech, Inc. Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
RU2006146939A (ru) 2004-06-09 2008-07-20 Дженентек Способ лечения кольцевидной гранулемы или саркоида

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080044T3 (es) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular y sus ligandos de fijacion.
AU629189B2 (en) * 1987-05-04 1992-10-01 Dana-Farber Cancer Institute Intercellular adhesion molecules and their binding ligands
HUT53672A (en) * 1988-02-25 1990-11-28 Gen Hospital Corp Quick immunoselective cloning process
ATE146968T1 (de) * 1989-03-16 1997-01-15 Blood Res Center Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie

Also Published As

Publication number Publication date
DE69029336D1 (de) 1997-01-23
CA2011633A1 (en) 1990-09-09
NO178862C (no) 1996-06-19
EP0387668A1 (en) 1990-09-19
KR900013978A (ko) 1990-10-22
NO901093D0 (no) 1990-03-08
AU647017B2 (en) 1994-03-17
FI100994B (fi) 1998-03-31
AU5117290A (en) 1990-09-13
EP0387668B1 (en) 1996-12-11
DE69029336T2 (de) 1997-07-03
CA2011633C (en) 2007-05-15
JP3369166B2 (ja) 2003-01-20
ES2097747T3 (es) 1997-04-16
MX9203469A (es) 1992-07-01
HU901367D0 (en) 1990-05-28
ATE146222T1 (de) 1996-12-15
IL93680A0 (en) 1990-12-23
HU214247B (hu) 1998-03-02
KR0169728B1 (ko) 1999-01-15
DK0387668T3 (da) 1997-03-03
NZ232833A (en) 1993-05-26
JPH0361486A (ja) 1991-03-18
NZ245651A (en) 1997-06-24
GR3022670T3 (en) 1997-05-31
NO901093L (no) 1990-09-10
NO178862B (no) 1996-03-11
IL93680A (en) 1996-01-31

Similar Documents

Publication Publication Date Title
FI901170A0 (fi) Intercellulaer adhesionmolekyl-2 och dess bindeligander.
FI882037A (fi) Intercellulaera adhesionmolekyler och deras bindande ligander.
DE68929477D1 (de) Interzellulare Adhäsions-Moleküle und deren Bindungsliganden
FI893916A (fi) Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: CENTER FOR BLOOD RESEARCH, INC.